Balancing safety and immunogenicity in live-attenuated mycobacterial vaccines for use in humans at risk for HIV: response to misleading comments in Ranganathan et al. "recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice"

Vaccine. 2010 May 7;28(21):3633-4. doi: 10.1016/j.vaccine.2010.03.025. Epub 2010 Mar 26.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • AIDS Vaccines / immunology*
  • Animals
  • HIV / immunology
  • HIV Infections / prevention & control*
  • Humans
  • Mice
  • Mice, SCID
  • Mycobacterium tuberculosis / immunology
  • Vaccines, Attenuated / immunology

Substances

  • AIDS Vaccines
  • Vaccines, Attenuated